Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 5 of 5 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Fenofibrate | 1件: Fenofibrate Fenofibrate (Mint-fenofibrate E) | 1件: Fenofibrate
Fenofibrate
(Fenofibrate) 💬1. Fenofibrate
| 1件: PPARA PPARA 💬1. Fenofibrate
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor ac ... | 6件: 8 8, 79, 93, 94, 97, 265 💬
| ||||||||||||||
| 2 | Fenofibrate 160mg | 1件: Fenofibrate Fenofibrate (Mint-fenofibrate E) | 1件: Fenofibrate
Fenofibrate
(Fenofibrate) 💬2. Fenofibrate 160mg
| 1件: PPARA PPARA 💬2. Fenofibrate 160mg
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor ac ... | 1件: 97 97 💬2. Fenofibrate 160mg
| ||||||||||||||
| 3 | Fenofibrate 200mg | 1件: Fenofibrate Fenofibrate (Mint-fenofibrate E) | 1件: Fenofibrate
Fenofibrate
(Fenofibrate) 💬3. Fenofibrate 200mg
| 1件: PPARA PPARA 💬3. Fenofibrate 200mg
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor ac ... | 1件: 93 93 💬3. Fenofibrate 200mg
| ||||||||||||||
| 4 | Fenofibrate Combined With Ursodeoxycholic Acid | 2件: Fenofibrate Fenofibrate (Mint-fenofibrate E),Ursodeoxycholic acid | 2件: Fenofibrate
Fenofibrate
(Fenofibrate),Ursodiol 💬 4. Fenofibrate Combined With Ursodeoxycholic Acid
| 2件: NR1H4 NR1H4,PPARA 💬 | 11件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 11件: Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenes ... | 1件: 93 93 💬4. Fenofibrate Combined With Ursodeoxycholic Acid
| ||||||||||||||
| 5 | Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle) | 1件: Fenofibrate Fenofibrate (Mint-fenofibrate E) | 1件: Fenofibrate
Fenofibrate
(Fenofibrate) 💬5. Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle)
| 1件: PPARA PPARA 💬5. Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle)
| 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor ac ... | 1件: 93 93 💬5. Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle)
|